The price of Beta Bionics Inc (NASDAQ:BBNX) shares last traded on Wall Street rose 1.83% to $11.14.
BBNX stock price is now -31.03% away from the 50-day moving average and -33.66% away from the 200-day moving average. The market capitalization of the company currently stands at $482.92M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $25, Stifel recently initiated with Buy rating for Beta Bionics Inc (NASDAQ: BBNX). On February 24, 2025, Piper Sandler recently initiated its ‘Overweight’ rating on the stock quoting a target price of $26, while ‘Leerink Partners’ rates the stock as ‘Outperform’
In other news, Mensinger Mike, Chief Product Officer bought 33,350 shares of the company’s stock on Jan 31 ’25. The stock was bought for $566,950 at an average price of $17.00. Upon completion of the transaction, the Chief Product Officer now directly owns 59,019 shares in the company, valued at $0.66 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 31 ’25, Chief Product Officer Mensinger Mike sold 13 shares of the business’s stock. A total of $221 was realized by selling the stock at an average price of $17.00. This leaves the insider owning 25,669 shares of the company worth $0.29 million. A total of 20.36% of the company’s stock is owned by insiders.
During the past 12 months, Beta Bionics Inc has had a low of $8.89 and a high of $24.50. As of last week, the company has a debt-to-equity ratio of 0.10, a current ratio of 6.29, and a quick ratio of 5.66. The fifty day moving average price for BBNX is $16.1511 and a two-hundred day moving average price translates $16.792454 for the stock.
The latest earnings results from Beta Bionics Inc (NASDAQ: BBNX) was released for 2024-12-31.
